Iovance Biotherapeutics Inc. buy Truist Financial Co.
Start price
27.12.23
/
50%
€6.20
Target price
27.12.24
€15.35
Performance (%)
77.53%
Price
15:30
€11.00
Summary
This prediction is currently active. With a performance of 77.53% the BUY prediction by Truist_Financial_Co_ is a big success. This prediction currently runs until 27.12.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Iovance Biotherapeutics Inc. | 2.211% | 2.211% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Iovance Biotherapeutics Inc. diskutieren
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $17.00 price target on the stock.
Ratings data for IOVA provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€5.09
15.09.23
15.09.23
€15.92
15.09.24
15.09.24
116.80%
15:30
15:30
